Form 4: Equillium Director Peter Colabuono Acquires 40,000 Stock Options

Director Peter Colabuono of Equillium, Inc. was granted 40,000 stock options on December 11, 2024.

Summary

• Peter Colabuono, a director at Equillium, Inc., was granted 40,000 stock options on December 11, 2024.
• The options have an exercise price of $0.70 per share.
• The options vest in 36 equal monthly installments starting from the grant date.
• The options expire on December 10, 2034.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction of stock options to a director, which is generally viewed as a neutral to slightly positive event as it aligns interests. There is no indication of any negative or unexpected news.

Positives

• The grant of stock options to a director aligns their interests with those of shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly traded companies.
• The vesting schedule of 36 months is typical for such grants.
• The exercise price of $0.70 is likely based on the current market price of the stock at the time of the grant.

Stakeholder Impact

• The stock option grant could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

stock options, director, equity, Equillium, insider trading, beneficial ownership